Summary: Many single-payer (nationally funded) healthcare systems pay a lot less for drugs, services, and equipment than US insurers do. They have a monopsony and therefore a lot of buying power--makes sense, right? Erik recently has a revelation that calls this logic into question... though without any clear answers. <br><br><p>Support this show <a target="_blank" rel="payment" href="http://supporter.acast.com/reconsiderpodcast">http://supporter.acast.com/reconsiderpodcast</a>.</p> <br><hr><p style="color: grey;">See <a style="color: grey;" target="_blank" rel="noopener noreferrer" href="https://acast.com/privacy">acast.com/privacy</a> for privacy and opt-out information.</p>
